Skip to main content

Table 2 Prevalence of resistance mutations using the WHO 2009 list for surveillance of transmitted drug resistance mutations

From: Prevalence and effect of pre-treatment drug resistance on the virological response to antiretroviral treatment initiated in HIV-infected children – a EuroCoord-CHAIN-EPPICC joint project

 

Number

Percent

95 % CI

At least 1 resistance mutation

37

7.8

5.5–10.6

  ≥ 1 NRTI resistance mutation

28

5.9

3.9–8.4

  ≥ 1 NNRTI resistance mutation

17

3.6

2.1–5.7

  ≥ 1 PI resistance mutation

3

0.6

0.1–1.8

Resistance mutations to 2 ARV classes

11

2.3

1.2–4.1

Resistance mutations to 3 ARV classes

0

0